This document provides information on diabetic ketoacidosis (DKA). It begins with an introduction stating that DKA is a life-threatening complication of diabetes mellitus that predominantly occurs in type 1 diabetes but can also occur in 10-30% of newly diagnosed type 2 diabetes cases. It then discusses the pathophysiology of DKA involving a complex relationship between insulin and counterregulatory hormones resulting in hyperglycemia, ketone formation, and metabolic acidosis. Clinical findings are related to hyperglycemia, volume depletion, and acidosis. Treatment goals are volume replacement, correction of hyperglycemia and electrolyte/acid-base imbalances, and treatment of underlying causes. A timeline is provided outlining management from initial presentation